XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2025
Sep. 29, 2024
Cash flows from operating activities:    
Net loss $ (84,343) $ (61,343)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 53,406 50,069
Amortization of lease acquisition 69 69
Amortization of loan origination fees 0 58
Amortization of cloud computing arrangements 752 682
Non-cash operating lease cost 26,098 23,312
Loss on fixed asset disposal 1,226 178
Stock-based compensation 24,032 30,214
Non-cash impairment and closure costs 9,754 73
Non-cash restructuring charges 636 525
Deferred income tax expense 270 270
Change in fair value of contingent consideration liability (2,066) 5,214
Change in fair value of contingent consideration liability (2,290) 0
Changes in operating assets and liabilities:    
Accounts receivable (1,771) (3,639)
Inventory (448) (34)
Prepaid expenses and other assets 1,873 1,408
Operating lease liabilities (32,175) (16,854)
Accounts payable 943 (421)
Accrued payroll and benefits (6,518) 833
Accrued expenses and other current liabilities 3,074 5,846
Gift card and loyalty liability 3,451 875
Other non-current liabilities (15) (64)
Net cash (used in) provided by operating activities (4,042) 37,271
Cash flows from investing activities:    
Purchase of property and equipment (76,149) (57,739)
Purchase of intangible assets (5,955) (5,458)
Security and landlord deposits 71 (2)
Net cash used in investing activities (82,033) (63,199)
Cash flows from financing activities:    
Proceeds from stock option exercise 3,014 9,704
Payment of contingent consideration 0 (3,868)
Payment associated to shares repurchased for tax withholding (261) 0
Net cash provided by financing activities 2,753 5,836
Net decrease in cash and cash equivalents and restricted cash (83,322) (20,092)
Cash and cash equivalents and restricted cash—beginning of year 217,429 257,355
Cash and cash equivalents and restricted cash—end of period 134,107 237,263
Cash paid for interest 11 184
Supplemental disclosure of cash flow information    
Purchase of property and equipment accrued in accounts payable and accrued expenses 12,819 9,387
Non-cash issuance of common stock associated with Spyce milestone achievement $ 0 $ 2,132